FDA announced on Dec. 23, 2014 that it had approved Roche Diagnostics Ebola test for emergency use. The LightMix Ebola Zaire rRT-PCR (real-time reverse transcription polymerase chain reaction) test is designed for use in patients with symptoms related to the Ebola Zaire virus. The testOriginal Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.